Altered growth hormone and prolactin responses to dopaminergic stimulation in huntington's chorea

Tommaso Caraceni, Alberto E. Panerai, Eugenio A. Parati, Daniela Cocchi, Eugenio E. Müller

Research output: Contribution to journalArticle

Abstract

Seven patients affected by Huntington's chorea were given an acute administration of 2-Br-α-ergocryptine (CB 154, Sandoz), a direct agonist at dopamine receptor sites. Seven nonobese hospitalized patients were used as controls. Oral administration of CB 154 (2.5 mg) induced a more prompt and consistent rise in plasma growth hormone (GH) levels in patients than in controls. GH levels rose from baseline values of 0.3 ±0.1 ng/ml to mean peak values of 20.4 ±5.1 ng/ml (120-270 min) in choreic subjects and from baseline values of 1.0 ± 0.4 ng/ml to mean peak values of 5.7 ± 1.6 ng/ml (180-300 min) in control subjects (P < 0.02). Baseline plasma prolactin (PRL) values were significantly higher in choreic than in control subjects (22.1 ± 6.6 ng/ml vs. 8.1 ± 1.4 ng/ml, respectively, P < 0.02); administration of CB 154 induced a more consistent PRL decrease in control than in choreic subjects. Collectively, these results suggest the existence of an abnormal regulation of GH and PRL secretion in Huntington's chorea, probably due to alterations in central dopaminergic neurotransmission.

Original languageEnglish
Pages (from-to)870-875
Number of pages6
JournalJournal of Clinical Endocrinology and Metabolism
Volume44
Issue number5
DOIs
Publication statusPublished - 1977

Fingerprint

Bromocriptine
Huntington Disease
Prolactin
Growth Hormone
Dopamine Agonists
Synaptic Transmission
Oral Administration
Plasmas
Dopamine Receptors

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Altered growth hormone and prolactin responses to dopaminergic stimulation in huntington's chorea. / Caraceni, Tommaso; Panerai, Alberto E.; Parati, Eugenio A.; Cocchi, Daniela; Müller, Eugenio E.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 44, No. 5, 1977, p. 870-875.

Research output: Contribution to journalArticle

Caraceni, Tommaso ; Panerai, Alberto E. ; Parati, Eugenio A. ; Cocchi, Daniela ; Müller, Eugenio E. / Altered growth hormone and prolactin responses to dopaminergic stimulation in huntington's chorea. In: Journal of Clinical Endocrinology and Metabolism. 1977 ; Vol. 44, No. 5. pp. 870-875.
@article{5eba3f8aba9f4df59b7650796c7b13fa,
title = "Altered growth hormone and prolactin responses to dopaminergic stimulation in huntington's chorea",
abstract = "Seven patients affected by Huntington's chorea were given an acute administration of 2-Br-α-ergocryptine (CB 154, Sandoz), a direct agonist at dopamine receptor sites. Seven nonobese hospitalized patients were used as controls. Oral administration of CB 154 (2.5 mg) induced a more prompt and consistent rise in plasma growth hormone (GH) levels in patients than in controls. GH levels rose from baseline values of 0.3 ±0.1 ng/ml to mean peak values of 20.4 ±5.1 ng/ml (120-270 min) in choreic subjects and from baseline values of 1.0 ± 0.4 ng/ml to mean peak values of 5.7 ± 1.6 ng/ml (180-300 min) in control subjects (P < 0.02). Baseline plasma prolactin (PRL) values were significantly higher in choreic than in control subjects (22.1 ± 6.6 ng/ml vs. 8.1 ± 1.4 ng/ml, respectively, P < 0.02); administration of CB 154 induced a more consistent PRL decrease in control than in choreic subjects. Collectively, these results suggest the existence of an abnormal regulation of GH and PRL secretion in Huntington's chorea, probably due to alterations in central dopaminergic neurotransmission.",
author = "Tommaso Caraceni and Panerai, {Alberto E.} and Parati, {Eugenio A.} and Daniela Cocchi and M{\"u}ller, {Eugenio E.}",
year = "1977",
doi = "10.1210/jcem-44-5-870",
language = "English",
volume = "44",
pages = "870--875",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Altered growth hormone and prolactin responses to dopaminergic stimulation in huntington's chorea

AU - Caraceni, Tommaso

AU - Panerai, Alberto E.

AU - Parati, Eugenio A.

AU - Cocchi, Daniela

AU - Müller, Eugenio E.

PY - 1977

Y1 - 1977

N2 - Seven patients affected by Huntington's chorea were given an acute administration of 2-Br-α-ergocryptine (CB 154, Sandoz), a direct agonist at dopamine receptor sites. Seven nonobese hospitalized patients were used as controls. Oral administration of CB 154 (2.5 mg) induced a more prompt and consistent rise in plasma growth hormone (GH) levels in patients than in controls. GH levels rose from baseline values of 0.3 ±0.1 ng/ml to mean peak values of 20.4 ±5.1 ng/ml (120-270 min) in choreic subjects and from baseline values of 1.0 ± 0.4 ng/ml to mean peak values of 5.7 ± 1.6 ng/ml (180-300 min) in control subjects (P < 0.02). Baseline plasma prolactin (PRL) values were significantly higher in choreic than in control subjects (22.1 ± 6.6 ng/ml vs. 8.1 ± 1.4 ng/ml, respectively, P < 0.02); administration of CB 154 induced a more consistent PRL decrease in control than in choreic subjects. Collectively, these results suggest the existence of an abnormal regulation of GH and PRL secretion in Huntington's chorea, probably due to alterations in central dopaminergic neurotransmission.

AB - Seven patients affected by Huntington's chorea were given an acute administration of 2-Br-α-ergocryptine (CB 154, Sandoz), a direct agonist at dopamine receptor sites. Seven nonobese hospitalized patients were used as controls. Oral administration of CB 154 (2.5 mg) induced a more prompt and consistent rise in plasma growth hormone (GH) levels in patients than in controls. GH levels rose from baseline values of 0.3 ±0.1 ng/ml to mean peak values of 20.4 ±5.1 ng/ml (120-270 min) in choreic subjects and from baseline values of 1.0 ± 0.4 ng/ml to mean peak values of 5.7 ± 1.6 ng/ml (180-300 min) in control subjects (P < 0.02). Baseline plasma prolactin (PRL) values were significantly higher in choreic than in control subjects (22.1 ± 6.6 ng/ml vs. 8.1 ± 1.4 ng/ml, respectively, P < 0.02); administration of CB 154 induced a more consistent PRL decrease in control than in choreic subjects. Collectively, these results suggest the existence of an abnormal regulation of GH and PRL secretion in Huntington's chorea, probably due to alterations in central dopaminergic neurotransmission.

UR - http://www.scopus.com/inward/record.url?scp=0017641395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017641395&partnerID=8YFLogxK

U2 - 10.1210/jcem-44-5-870

DO - 10.1210/jcem-44-5-870

M3 - Article

C2 - 140180

AN - SCOPUS:0017641395

VL - 44

SP - 870

EP - 875

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 5

ER -